Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy
- PMID: 17357126
- DOI: 10.1002/ana.21110
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy
Abstract
We conducted a randomized, double-blind, placebo-controlled, single-patient (N = 1) trial to evaluate the efficacy of zolpidem in a 48-year-old woman with an akinetic mutism. Motor and cognitive examinations and functional imaging were performed. Acute administration of zolpidem markedly improved motor performance and neuropsychological status. Cerebral metabolism ((18)F-fluorodeoxyglucose positron emission tomography) increased in postrolandic territories and in frontal cortex. Using the H(2) (15)O positron emission tomography, we found a drug-induced activation in the anterior cingulate and orbitofrontal cortices. Zolpidem induced a transient improvement in motor and cognitive performances. This paradoxical effect could result from an activation of limbic loops modulating motivational processes.
Comment in
-
Another "Awakenings".Ann Neurol. 2007 Jul;62(1):5-7. doi: 10.1002/ana.21158. Ann Neurol. 2007. PMID: 17514746 No abstract available.
-
Zolpidem and its effects on hypoxic encephalopathy.Ann Neurol. 2008 Oct;64(4):477-8. doi: 10.1002/ana.21183. Ann Neurol. 2008. PMID: 17702026 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
